Edhel Tripon (@EdhelTripon) header
Edhel Tripon (@EdhelTripon) profile picture

Believer, multitasking motherboard and wife, liver doc, hepatitis and liver health advocate, tries to run, reluctant multi-pet owner

Republic of the Philippines
Joined February 2019
Seeing Babymetal with the family tomorrow! We hope to be able to get these to you, #メタラジ!🤟🫶 #Babymetalfans help us get this to them! #BABYMETALWORLDTOUR2025 #BabyMetalManila2025 #babymetalfanart
2
190
Exercise before breakfast in the fasting state is more beneficial than postprandial morning exercise for improving liver fat and A1c. journals.lww.com/acsm-msse/f…
5
124
8
455
31,678
Another outcomes trial win for GLP-1 medicines now with Semaglutide and the ESSENCE trial in metabolic liver disease with reduction in both inflammation and fibrosis #MASH novonordisk.com/content/nnco…
5
66
5
217
45,047
Edhel Tripon retweeted
Nakwento ko na dati ito dito sa Twitter (X na pala)- pero ngayon ko lang nailagay sa slides. Kung gusto talaga nating magkaroon ng madaming travel options, kailangan nating simulan sa paglalakad. Pedestrian dapat ang priority. Pedestrian tayong lahat. nitter.cf/cxteam_lim/status/1603…
Isang halimbawa: Pansinin ang sidewalk sa pagliko mula CP Garcia papuntang Katipunan. Dati, pwedeng dalawang tao kahit nakapayong pa. Ngayon, hindi na. Bakit? 1/
2
9
23
1,487
This important study shows three lessons: 🔸Cirrhosis is frequently underdiagnosed. 🔸Alcohol is the leading cause. 🔸HCC is not adequately screened. Early diagnosis of silent cirrhosis can save lives ! t.ly/8SoPI
5
57
3
135
14,391
Shout out and appreciation to all our extraordinary Radiology friends who go above and beyond, ask questions about the history, and are willing to look again when asked ! You help us solve mysteries and save lives everyday. Can't imagine doing Liver and GI without you guys!
2
84
Reposting for #TLM2024. Taco crawl
This Post is from an account that no longer exists. Learn more
1
155
Screening Strategies for High-Risk MASLD in Primary Care are cost-effective.👍💰👍 Pharmaco-economic study:👉onlinelibrary.wiley.com/doi/… @Echosens @semfyc @SEMERGEN_CV @redGDPS @NovoNordiskES @EASLnews
2
23
1
59
3,545
Edhel Tripon retweeted
How many people visiting diabetes clinic have advanced liver fibrosis? Lots Laurent went to diabetes clinic and convinced 300 people to get a liver biopsy. 1 of every 3 had advanced fibrosis These are the people at risk for liver cancer, ascites, encephalopathy #IMTLD2024
8
33
2
121
13,982
Even more frustrating when you know it's impossible to get one due to access issues :(
It's #OrganDonatiomWeek!! Please consider joining the #OrganDonorRegister. Nearly 8,000 UK children and adults waiting for life saving #transplants. It could be you! Please #ShareYourWishes with your family as they have to give consent. #LiverTwitter. #CKD #Heart #Lungs
1
96
MASLD Natural History * 3% develop major adverse liver events within 2 decades ( 3 out of 100!) - seems small - but the MASLD burden is Ginormous! *Estimated progression to Cirrhosis (for those who progress) F0-F1 --> 3 decades F2 --> 2 decades F3 --> 6 years
This Post is from an account that no longer exists. Learn more
1
183
🚨#livertwitter #SpleenStiffness Measurement #SSM by dedicated 100Hz #VCTE #Fibroscan probe improves #PortalHypertension risk assessment 🎯 #NICER model by @mathiasjachs @MattiasMandorf1 for the @BavenoCoop published @LancetGastroHep 📕t.ly/bL_wv
4
23
1
59
3,448
More options, more reason to MDT for HCC!
New data for #intermediate #HCC at #ESMO24 from LEAP-012 trial 👍🏻PFS/ORR benefit for LenvaPembro+TACE (vs TACE) 🤞🏻OS promising 🤝Toxicity acceptable 👉Systemic+TACE as SOC may be close to be a reality!! (2nd +ve study 😉 EMERALD-1) @myESMO #ESMOAmbassadors @GrupoTTD @EASLnews
2
67
Edhel Tripon retweeted
TACE +/- lenva + pembro for intermediate-stage HCC #ESMO24 🔎Phs III LEAP-012 👉ORR 46 vs 33% (RECIST) 👉ORR 71 vs 49% (mRECIST) 👉mPFS 10 vs 14.6 mo 👉mOS not mature 👉AE ≥3 31% vs 71% 🧐strong ORR and PFS data, already practice-changing? @myESMO #ESMOAmbassadors
3
41
1
80
9,495
Confused by BRTO, CARTO, PARTO? This slide from Ken Chan is for you! Just say, "embolization of varices" #livertwitter #AGW2024
2
33
105
13,409
Less=More w #antibiotics in #cirrhosis & ✅ reconsider #SecSBPProphylaxis @AmJGastro⤵️ pubmed.ncbi.nlm.nih.gov/3923… 🔑#SecSBPPr vs others▶️⬆️SBP recurrence &🚫mortality benefit 🔑2 datasets (@VAResearch & @TriNetX) w similar trends 🔑worsens over time & validated locally @ABsteward
1
55
7
110
39,081
Tirzepatide was associated with 48% decreased kidney events compared to GLP1 RA, in a retrospective analysis of 140,308 patients with type 2 diabetes. Also with: ⬇️ 20% 🫀MACE ⬇️ 42% ☠️all cause mortality ⬇️ 0.34% a1c ⬇️2.9kg body weight We need full randomized clinical trials before we can make conclusions of clear superiority jamanetwork.com/journals/jam…
6
35
1
128
15,752
Tirzepatide has a greater A1c level and body weight reduction than semaglutide, particularly with the higher doses. link.springer.com/article/10…
4
45
3
154
17,023
Two @NEJM papers testing dual/enhanced GLP-1 receptor agonist–based treatments in MASH. Phase-2 trials on Tirzepatide & Survodutide by @DrLoomba & @ArunJSanyalVCU showed promising results to be confirmed in Phase-3 studies. t.ly/5Rlyz t.ly/iH6xv
2
17
1
49
3,809